Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.690
+0.070 (4.32%)
At close: Jan 16, 2026, 4:00 PM EST
1.710
+0.020 (1.18%)
After-hours: Jan 16, 2026, 7:56 PM EST
Ocugen Market Cap
Ocugen has a market cap or net worth of $527.82 million as of January 16, 2026. Its market cap has increased by 125.07% in one year.
Market Cap
527.82M
Enterprise Value
528.22M
1-Year Change
125.07%
Ranking
Category
Stock Price
$1.69
Market Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $527.82M, an increase of 1,511.70%. That is a compound annual growth rate of 55.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 527.82M | 25.19% |
| Dec 31, 2025 | 421.63M | 79.79% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |